◄ back to all posts

FRX: Forest Laboratories Inc Stock

Written by | Jul 6, 2018
Print Friendly, PDF & EmailPrint Friendly

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) -1,300.27
Book Value ($M) 6,165.56
Book Value / Share 22.62
Price / Book 0.08
NCAV ($M) -1,728.26
NCAV / Share -6.34
Price / NCAV -0.28

Profitability (mra)
Return on Invested Capital (ROIC) 0.03
Return on Assets (ROA) 0.02
Return on Equity (ROE) 0.03

Liquidity (mrq)
Quick Ratio 2.32
Current Ratio 2.73

Balance Sheet (mrq) ($M)
Current Assets 4,123.71
Assets 12,017.53
Liabilities 5,851.97
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 3,646.90
Operating Income 111.75
Net Income 165.31

Cash Flow Statement (mra) ($M)
Cash From Operations 470.90
Cash from Investing -2,772.10
Cash from Financing -2,772.10

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
2014-07-10 13G/A BlackRock Inc. 4.40
2014-07-01 13D/A Icahn Carl C 0.00
2014-06-10 13G/A Wellington Management Group Llp 8.69
2014-02-14 13G/A Clearbridge Investments, LLC 7.94
2014-02-13 13G/A Capital Research Global Investors 0.00
2014-02-11 13G/A Vanguard Group Inc 6.07
2014-02-04 13G/A Vanguard Specialized Funds 9.89
2012-08-09 13G/A Morgan Stanley 0.30

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

Similar Companies
CTLT – Catalent Inc. EBS – Emergent Biosolutions, Inc.
ELAN – Elanco Animal Health Inc GSK – GlaxoSmithKline plc
HEXO – HEXO Corp.


Financial data and stock pages provided by
Fintel.io




Post Views: 0
2018/07/06

Also Read

◄ back to all posts

401 K